Viewing Study NCT03127618


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2026-03-13 @ 8:40 AM
Study NCT ID: NCT03127618
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2020-05-15
First Post: 2017-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lorlatinib - PF-06463922
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:
Keywords: